Network identification

PURI

https://redirect.ema.europa.eu/resource/49628

Network ID

49628

Network name and Acronym

Data Analysis and Real World Interrogation Network (DARWIN EU®)

Network countries

Belgium
Croatia
Denmark
Estonia
Finland
France
Germany
Hungary
Netherlands
Norway
Portugal
Spain
United Kingdom

Network website

ENCePP partner

No
Network details
Network funding:
Other

Contact

Institutions that are part of this network

Finnish Institute for Health and Welfare (THL)
Clinical Practice Research Datalink (CPRD)
Department of Medical Informatics - Health Data Science, Erasmus Medical Center (ErasmusMC)
Real-World-Evidence, IQVIA NL
Real World Solutions, IQVIA
Fundació Institut Universitari per a la Recerca a l'Atenció Primària de Salut Jordi Gol i Gurina, IDIAPJGol
Clinical Data Science (IKNL), Netherlands Comprehensive Cancer Organisation
Data Analytic Center (DAC), Danish Medicine Agency
Southwest Finland Wellbeing Services County (VarHa)
Pharmaco- and Device epidemiology, University of Oxford
Parc de Salut Mar Barcelona (PSMAR)
Bordeaux University Hospital (CHU de Bordeaux)
University of Tartu
Clinical Academic Center Egas Moniz (CAC-EMHA)
Unidade Local de Saúde de Matosinhos (ULSM)
Semmelweis University
The Foundation for the Promotion of Health and Biomedical Research of Valencia Region (FISABIO)
Agencia Española de Medicamentos y Productos Sanitarios (Spanish Agency for Medicines and Medical Devices, AEMPS)
University of Oslo

Studies conducted by the network

DARWIN EU® – Paracetamol prescribing and paracetamol overdose in Europe: a descriptive analysis of trends and patient characteristics
DARWIN EU® - Antipsychotic prescribing in older people in Europe: a descriptive analysis of trends and patient characteristics
DARWIN EU® - Azathioprine - user characteristics
DARWIN EU® - Background incidence rates of selected vaccine adverse events of special interest (AESIs) in Europe
DARWIN EU® - Background rates of serious adverse events to contextualise safety assessments in clinical trials and non-interventional studies in adolescent and adult patients with severe asthma
DARWIN EU® - CGRP antagonists - Treatment patterns and users characteristics
DARWIN EU® - Characterising interstitial lung disease in Europe
DARWIN EU® - Chondrosarcoma: patient demographics, treatments, and survival in the period 2010-2023
DARWIN EU® - Drug Utilisation Study on GLP-1 Receptor Agonists
DARWIN EU® - Drug utilisation study on medicinal use of cannabis flos
DARWIN EU® - Drug utilisation study on medicinal use of Pelargonii radix
DARWIN EU® - Incidence of suicidality in patients with specific chronic skin conditions
DARWIN EU® Age specific incidence rates of RSV related disease in Europe
DARWIN EU® Characterization of patients with chronic hepatitis B and C
DARWIN EU® Comparing direct and indirect methods to estimate prevalence of chronic diseases using real-world data
DARWIN EU® Drug utilisation of valproate-containing medicinal products in women of childbearing potential
DARWIN EU® Drug utilisation study of medicines with prokinetic properties in children and adults diagnosed with gastroparesis
DARWIN EU® DUS of Antibiotics in the ‘Watch’ category of the WHO AWaRe classification of antibiotics for evaluation and monitoring of use
DARWIN EU® Effectiveness of COVID-19 vaccines on severe COVID-19 and post acute outcomes of SARS-CoV-2 infection
DARWIN EU® Effectiveness of Human Papillomavirus Vaccines (HPV) to prevent cervical cancer
DARWIN EU® EHDS Use Case: Natural history of coagulopathy in COVID-19 patients and persons vaccinated against SARS-CoV-2 in the context of the OMICRON variant
DARWIN EU® Monitoring prescription of essential medicines administered in ICU
DARWIN EU® Monitoring prescription of medicines for public health emergencies at risk of shortages
DARWIN EU® Multiple myeloma: patient characterisation, treatments and survival in the period 2012-2022
DARWIN EU® Natural history of dermatomyositis (DM) and polymyositis (PM) in adults and paediatric populations
DARWIN EU® Overall survival in patients with locally advanced or metastatic non-small cell lung cancer treated with selected immunotherapies as first line of treatment
DARWIN EU® Prevalence of rare blood cancers in Europe
DARWIN EU® Rates of occurrence of treatment-related intercurrent events in patients with major depressive disorder
DARWIN EU® Treatment patterns of drugs used in adult and paediatric population with systemic lupus erythematosus
DARWIN EU® Use of take-home naloxone for opioid overdose treatment
DARWIN EU® – Frailty and polypharmacy among adults with selected cancers at the time of diagnosis
DARWIN EU® – Trends in utilisation of Attention-Deficit Hyperactivity Disorder (ADHD) Medications